COVID-19
Epidemiology
Basic science
Aims : This session will discuss the evolving epidemiology of coronavirus disease 2019 (COVID-19), covering the global view from the World Health Organisation (WHO), updates on symptom tracking, risk factors and the severity biomarkers post infection.
Key references:
1: Menni C, Valdes AM, Freidin MB, Sudre CH, Nguyen LH, Drew DA, Ganesh S, Varsavsky T, Cardoso MJ, El-Sayed Moustafa JS, Visconti A, Hysi P, Bowyer RCE, Mangino M, Falchi M, Wolf J, Ourselin S, Chan AT, Steves CJ, Spector TD. Real-time tracking of self-reported symptoms to predict potential COVID-19. Nat Med.2020 Jul;26(7):1037-1040. doi: 10.1038/s41591-020-0916-2. Epub 2020 May 11.PMID: 32393804.
2: Drew DA, Nguyen LH, Steves CJ, Menni C, Freydin M, Varsavsky T, Sudre CH, Cardoso MJ, Ourselin S, Wolf J, Spector TD, Chan AT; COPE Consortium. Rapid implementation of mobile technology for real-time epidemiology of COVID-19. Science. 2020 Jun 19;368(6497):1362-1367. doi: 10.1126/science.abc0473. Epub 2020 May 5. PMID: 32371477; PMCID: PMC7200009.
3: Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, Norman L, Holden KA, Read JM, Dondelinger F, Carson G, Merson L, Lee J, Plotkin D, Sigfrid L, Halpin S, Jackson C, Gamble C, Horby PW, Nguyen-Van-Tam JS, Ho A, Russell CD, Dunning J, Openshaw PJ, Baillie JK, Semple MG; ISARIC4C investigators. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. 2020 May 22;369:m1985. doi: 10.1136/bmj.m1985. PMID: 32444460; PMCID: PMC7243036.
Methods :
Epidemiology, Public health
10:50
Introduction
1
COV3611
10:55
European and world-view
N. Shindo(Genève, Switzerland)
COI
2
COV3612
11:10
Risk factors for severe COVID-19 and the ISARIC 4C Mortality Score, evidence from the ISARIC Coronavirus Clinical Characterisation Consortium
C. Semple(Liverpool, United Kingdom)
COI
3
COV3614
11:25
Severity biomarkers once infected
E. Polverino(Barcelona, Spain)
COI
4
COV3615
11:40
Discussion and questions and answers
5
COV3616